Finance

Beta
Lists
CERS:NASDAQ
Cerus Corp
$3.15
+0.32%
(+0.0100) 1D
$3.15
0.00% (0.00)
After hours
Closed: Jul 9, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CERS...
Open
$3.20
High
$3.25
Low
$3.12
Mkt. cap
647.24M
Avg. vol.
2.84M
Volume
1.37M
52-wk high
$3.47
52-wk low
$1.15
EPS
-$0.05
Beta
1.77
Shares outstanding
200.37M
No. of employees
268
Open
$3.20
High
$3.25
Low
$3.12
Mkt. cap
647.24M
Avg. vol.
2.84M
Volume
1.37M
52-wk high
$3.47
52-wk low
$1.15
EPS
-$0.05
Beta
1.77
Shares outstanding
200.37M
No. of employees
268
News stories
From sources across the web
Profile
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry. Wikipedia
About Cerus Corp
CEO-
Employees268
FoundedSep 1991
HeadquartersConcord, California, United States
SectorMedical device
Websitecerus.com
Analyst ratings
Based on 3 analysts giving stock ratings to CERS in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for CERS in the last 3 months.
Highest
Current $3.15
$5.00 (+58.73%)
Average
$4.50 (+42.86%)
Lowest
$4.00 (+26.98%)
Analyst
Recommendation
Action
Price target
Projected
Date
Josh Jennings
TD Cowen
Buy
Reiterated
$5.00
+58.7%
05/27/2026
William Bonello
Craig-Hallum
Buy
Maintained
-
-
05/01/2026
Mark Massaro
BTIG
Buy
Upgraded
$4.00
+27%
05/01/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
52.44M
52.70M
57.75M
53.66M
Cost of goods sold
23.47M
24.56M
28.00M
25.77M
Cost of revenue
23.47M
24.56M
28.00M
25.77M
Research and development expenses
18.90M
15.82M
16.39M
14.53M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
21.18M
18.62M
20.83M
19.95M
Operating expense
32.40M
26.90M
30.39M
28.25M
Total operating expenses
55.87M
51.46M
58.39M
54.02M
Operating income
-3.42M
1.24M
-641.00K
-354.00K
Other non operating income
845.00K
976.00K
578.00K
520.00K
EBT including unusual items
-5.64M
65.00K
-2.06M
-1.56M
EBT excluding unusual items
-5.64M
65.00K
-2.08M
-1.56M
Income tax expense
76.00K
85.00K
119.00K
91.00K
Effective tax rate
-1.35%
130.77%
-5.76%
-5.84%
Other operating expenses
-7.68M
-7.54M
-6.83M
-6.23M
Net income
-5.71M
-19.00K
-2.18M
-1.64M
Net profit margin
-10.88%
-0.04%
-3.78%
-3.06%
Earnings per share
-0.03
-
-0.01
-0.01
Interest and investment income
-
-
-
-
Interest expense
-2.15M
-2.12M
-1.96M
-1.87M
Net interest expenses
-2.15M
-2.12M
-1.96M
-1.87M
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.08M
1.62M
-248.00K
93.00K
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer